E12 Ventures invests in early-stage, disruptive healthcare and life sciences companies, focusing on founders with deep domain expertise and innovative solutions that address significant market needs. They seek to partner with entrepreneurs who are building the next generation of healthcare.
About E12 Ventures
E12 Ventures is an early-stage venture firm with website, LinkedIn, and Crunchbase footprint, with positioning that suggests a thematic or generalist technology focus, though the source data does not disclose specific stage, sector, healthcare exposure, or check size detail. The name E12 may reference a numerical or technical concept relevant to the firm’s thesis. For healthcare AI founders, E12 should be treated as a generalist or thematic early-stage potential investor with no confirmed healthcare specialization unless verified through direct conversation. Plausible check sizing at this profile is $250K to $1.5M at seed, often as a co-investor though potentially leading smaller rounds. The most likely fit, if any, is for software-style healthcare AI companies with capital-efficient unit economics, rather than biotech, regulated devices, or care delivery models requiring deep clinical or payer expertise. Founders building deeply clinical or regulatory-heavy products should look to specialist healthcare investors first. The firm’s value-add is harder to predict without disclosed thesis or recent portfolio data; founders should ask directly during initial outreach. Entry path is LinkedIn outreach to the partners, the website inquiry form, or warm referral from a portfolio CEO. Founders should reverse-diligence by asking for recent investments, fund size, ownership targets, and any healthcare exposure before significant pitch preparation. Be honest about the data gap: at this level of public signal, founder time should be limited until clearer signals of thesis alignment surface, and disclosed-thesis healthcare investors should be prioritized first in fundraising sequencing. Treat as opportunistic capacity rather than a strategic lead.
Founder reviews
Healthcare AI tools backed by E12 Ventures
Tools made by companies in E12 Ventures's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in E12 Ventures's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from E12 Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).